Lapatinib Resistance Confers Cross-Resistance to Microtubule Inhibitors in ErbB2-Overexpressing Breast Cancer Cells

被引：0
|
作者：
Araki, K. [1 ]
Gallas, M. [1 ]
Liu, X. [1 ]
Jegg, A-M [1 ]
Ward, T. [1 ]
Pegram, M. [1 ]
机构：
[1] Univ Miami, Coral Gables, FL 33124 USA
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-01-05
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Elevated expression of erbB3 confers paclitaxel resistance in erbB2-overexpressing breast cancer cells via upregulation of Survivin
    Wang, S.
    Huang, X.
    Lee, C-K
    Liu, B.
    [J]. ONCOGENE, 2010, 29 (29) : 4225 - 4236
  • [2] Adjuvant and neoadjuvant therapy with lapatinib in ErbB2-overexpressing breast cancer
    Janni, Wolfgang
    von Minckwitz, Gunter
    Moebus, Volker
    Nitz, Ulrike
    [J]. BREAST CARE, 2008, 3 : 17 - 20
  • [3] Elevated expression of erbB3 confers paclitaxel resistance in erbB2-overexpressing breast cancer cells via upregulation of Survivin
    S Wang
    X Huang
    C-K Lee
    B Liu
    [J]. Oncogene, 2010, 29 : 4225 - 4236
  • [4] Mitotic Deregulation by Survivin in ErbB2-Overexpressing Breast Cancer Cells Contributes to Taxol Resistance
    Lu, Jing
    Tan, Ming
    Huang, Wen-Chien
    Li, Ping
    Guo, Hua
    Tseng, Ling-Ming
    Su, Xiao-Hua
    Yang, Wen-Tao
    Treekitkarnmongkol, Warapen
    Andreeff, Michael
    Symmans, Fraser
    Yu, Dihua
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (04) : 1326 - 1334
  • [5] Clinical experience with lapatinib in patients with ErbB2-overexpressing metastatic breast cancer
    Harbeck, Nadia
    Heinemann, Volker
    Loibl, Sibylle
    Untch, Michael
    [J]. BREAST CARE, 2008, 3 : 7 - 12
  • [6] Differential effects of erbB3 and IGF-1R signaling on lapatinib resistance acquired by the erbB2-overexpressing breast cancer cells refractory to trastuzumab
    Lyu, Hui
    Huang, Jingcao
    Lee, Youngseok
    Liu, Bolin
    [J]. MOLECULAR CANCER RESEARCH, 2013, 11
  • [7] Assessment of neratinib-resistance and cross-resistance in HER2-overexpressing breast cancer cells.
    Breslin, Susan
    Corcoran, Claire
    Rani, Sweta
    Crown, John
    O'Driscoll, Lorraine
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Heat shock factor 1 confers resistance to lapatinib in ERBB2-positive breast cancer cells
    Alisha Yallowitz
    Amr Ghaleb
    Lucas Garcia
    Evguenia M. Alexandrova
    Natalia Marchenko
    [J]. Cell Death & Disease, 9
  • [9] Heat shock factor 1 confers resistance to lapatinib in ERBB2-positive breast cancer cells
    Yallowitz, Alisha
    Ghaleb, Amr
    Garcia, Lucas
    Alexandrova, Evguenia M.
    Marchenko, Natalia
    [J]. CELL DEATH & DISEASE, 2018, 9
  • [10] Upregulation of DARPP32/PPP1R1B is a critical mediator of acquired lapatinib resistance in ErbB2-overexpressing breast cancer cells
    Ma, Zhikun
    Howard, Erin W.
    Parris, Amanda B.
    Yang, Xiaohe
    [J]. CANCER RESEARCH, 2018, 78 (13)
12345